Bausch Tangible Asset Value from 2010 to 2026
| BHC Stock | USD 5.76 0.02 0.35% |
Tangible Asset Value | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Bausch Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bausch Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 906.4 M, Interest Expense of 1.7 B or Selling General Administrative of 3 B, as well as many indicators such as Price To Sales Ratio of 0.34, Dividend Yield of 0.0534 or Days Sales Outstanding of 95.55. Bausch financial statements analysis is a perfect complement when working with Bausch Health Valuation or Volatility modules.
Bausch | Tangible Asset Value | Build AI portfolio with Bausch Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out the analysis of Bausch Health Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Pharmaceuticals sector continue expanding? Could Bausch diversify its offerings? Factors like these will boost the valuation of Bausch Health. Projected growth potential of Bausch fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bausch Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 13.68 | Earnings Share 1 | Revenue Per Share | Quarterly Revenue Growth 0.068 | Return On Assets |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bausch Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bausch Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bausch Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.